Bryan Haugen
Mary Rossick Kern and Jerome H. Kern Chair in Endocrine Neoplasms Research
Credentials: · ·
History
Present
- Until 1993
- Until 1990
- Until 1988
Research
Thyroid · 2016 · First of 16 authors · 11,107 citations
Thyroid · 2009 · 5,173 citations
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
Thyroid · 2006 · 1,486 citations
24 papers
24 papers
16 papers
16 papers
16 papers
15 papers
- DR
15 papers
- JK
15 papers · 2 as a fellow
Grants
- 2019–2025
Chromosomal Instability as a Therapeutic Target in Anaplastic Thyroid Cancer
National Cancer Institute · R01
Contact PI · $2.3M · University of Colorado Denver
- 2013–2019
TXNIP as a Key Regulator of Thyroid Cancer Metabolism and Aggressiveness
National Cancer Institute · R01
Contact PI · $1.6M · University of Colorado Denver
- 2011–2017
The NFkB-Dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer
National Cancer Institute · R01
Contact PI · $1.5M · University of Colorado Denver
- 2009–2012
A Validated Resource of Thyroid Cancer Cell Lines for Pathway Discovery
National Cancer Institute · RC1
Contact PI · $999.9K · University of Colorado Denver
Clinical trials
- 2018–2023
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
Principal investigator · Completed · Phase 2
Academic and Community Cancer Research United
- 2016–2020
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
Principal investigator · Terminated
University of Colorado, Denver